56 related articles for article (PubMed ID: 21796525)
1. Methods to study dynamic interaction of androgen receptor with chromatin in living cells.
Kirli HZ; Saatcioglu F
Methods Mol Biol; 2011; 776():131-45. PubMed ID: 21796525
[TBL] [Abstract][Full Text] [Related]
2. Single-cell analysis of glucocorticoid receptor action reveals that stochastic post-chromatin association mechanisms regulate ligand-specific transcription.
Voss TC; John S; Hager GL
Mol Endocrinol; 2006 Nov; 20(11):2641-55. PubMed ID: 16873444
[TBL] [Abstract][Full Text] [Related]
3. Quantifying effects of ligands on androgen receptor nuclear translocation, intranuclear dynamics, and solubility.
Marcelli M; Stenoien DL; Szafran AT; Simeoni S; Agoulnik IU; Weigel NL; Moran T; Mikic I; Price JH; Mancini MA
J Cell Biochem; 2006 Jul; 98(4):770-88. PubMed ID: 16440331
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of gene targeting and chromatin remodelling by nuclear receptors.
Hager GL; Fletcher TM; Xiao N; Baumann CT; Müller WG; McNally JG
Biochem Soc Trans; 2000; 28(4):405-10. PubMed ID: 10961929
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of histone deacetylation augments dihydrotestosterone induction of androgen receptor levels: an explanation for trichostatin A effects on androgen-induced chromatin remodeling and transcription of the mouse mammary tumor virus promoter.
List HJ; Smith CL; Rodriguez O; Danielsen M; Riegel AT
Exp Cell Res; 1999 Nov; 252(2):471-8. PubMed ID: 10527637
[TBL] [Abstract][Full Text] [Related]
6. Antiandrogens prevent stable DNA-binding of the androgen receptor.
Farla P; Hersmus R; Trapman J; Houtsmuller AB
J Cell Sci; 2005 Sep; 118(Pt 18):4187-98. PubMed ID: 16141232
[TBL] [Abstract][Full Text] [Related]
7. Comparison of chromatin remodeling and transcriptional activation of the mouse mammary tumor virus promoter by the androgen and glucocorticoid receptor.
List HJ; Lozano C; Lu J; Danielsen M; Wellstein A; Riegel AT
Exp Cell Res; 1999 Aug; 250(2):414-22. PubMed ID: 10413595
[TBL] [Abstract][Full Text] [Related]
8. The androgen receptor ligand-binding domain stabilizes DNA binding in living cells.
Farla P; Hersmus R; Geverts B; Mari PO; Nigg AL; Dubbink HJ; Trapman J; Houtsmuller AB
J Struct Biol; 2004 Jul; 147(1):50-61. PubMed ID: 15109605
[TBL] [Abstract][Full Text] [Related]
9. FRAP and FRET methods to study nuclear receptors in living cells.
van Royen ME; Dinant C; Farla P; Trapman J; Houtsmuller AB
Methods Mol Biol; 2009; 505():69-96. PubMed ID: 19117140
[TBL] [Abstract][Full Text] [Related]
10. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
11. Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor.
Doesburg P; Kuil CW; Berrevoets CA; Steketee K; Faber PW; Mulder E; Brinkmann AO; Trapman J
Biochemistry; 1997 Feb; 36(5):1052-64. PubMed ID: 9033395
[TBL] [Abstract][Full Text] [Related]
12. Compartmentalization of androgen receptor protein-protein interactions in living cells.
van Royen ME; Cunha SM; Brink MC; Mattern KA; Nigg AL; Dubbink HJ; Verschure PJ; Trapman J; Houtsmuller AB
J Cell Biol; 2007 Apr; 177(1):63-72. PubMed ID: 17420290
[TBL] [Abstract][Full Text] [Related]
13. A differential ligand-mediated response of green fluorescent protein-tagged androgen receptor in living prostate cancer and non-prostate cancer cell lines.
Nakauchi H; Matsuda K; Ochiai I; Kawauchi A; Mizutani Y; Miki T; Kawata M
J Histochem Cytochem; 2007 Jun; 55(6):535-44. PubMed ID: 17312014
[TBL] [Abstract][Full Text] [Related]
14. Effects of antiandrogens on chromatin remodeling and transcription of the integrated mouse mammary tumor virus promoter.
List HJ; Smith CL; Martinez E; Harris VK; Danielsen M; Riegel AT
Exp Cell Res; 2000 Oct; 260(1):160-5. PubMed ID: 11010820
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence recovery after photobleaching (FRAP) to study nuclear protein dynamics in living cells.
van Royen ME; Farla P; Mattern KA; Geverts B; Trapman J; Houtsmuller AB
Methods Mol Biol; 2009; 464():363-85. PubMed ID: 18951195
[TBL] [Abstract][Full Text] [Related]
16. FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells.
Takayama K; Horie-Inoue K; Ikeda K; Urano T; Murakami K; Hayashizaki Y; Ouchi Y; Inoue S
Biochem Biophys Res Commun; 2008 Sep; 374(2):388-93. PubMed ID: 18640093
[TBL] [Abstract][Full Text] [Related]
17. Interrogating androgen receptor function in recurrent prostate cancer.
Zhang L; Johnson M; Le KH; Sato M; Ilagan R; Iyer M; Gambhir SS; Wu L; Carey M
Cancer Res; 2003 Aug; 63(15):4552-60. PubMed ID: 12907631
[TBL] [Abstract][Full Text] [Related]
18. Sterol regulatory element-binding protein-1c represses the transactivation of androgen receptor and androgen-dependent growth of prostatic cells.
Suh JH; Gong EY; Kim JB; Lee IK; Choi HS; Lee K
Mol Cancer Res; 2008 Feb; 6(2):314-24. PubMed ID: 18245227
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of mammalian NER proteins.
Vermeulen W
DNA Repair (Amst); 2011 Jul; 10(7):760-71. PubMed ID: 21550320
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
